AU2003232844A1 - Morpholin-acetamide derivatives for the treatment of inflammatory diseases - Google Patents

Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Info

Publication number
AU2003232844A1
AU2003232844A1 AU2003232844A AU2003232844A AU2003232844A1 AU 2003232844 A1 AU2003232844 A1 AU 2003232844A1 AU 2003232844 A AU2003232844 A AU 2003232844A AU 2003232844 A AU2003232844 A AU 2003232844A AU 2003232844 A1 AU2003232844 A1 AU 2003232844A1
Authority
AU
Australia
Prior art keywords
morpholin
treatment
inflammatory diseases
acetamide derivatives
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232844A
Inventor
Caroline Mary Cook
Colin David Eldred
Lee Andrew Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003232844A1 publication Critical patent/AU2003232844A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003232844A 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases Abandoned AU2003232844A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0212355.2 2002-05-29
GB0212355A GB0212355D0 (en) 2002-05-29 2002-05-29 Novel compounds
PCT/EP2003/005717 WO2003099287A1 (en) 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
AU2003232844A1 true AU2003232844A1 (en) 2003-12-12

Family

ID=9937625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232844A Abandoned AU2003232844A1 (en) 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Country Status (3)

Country Link
AU (1) AU2003232844A1 (en)
GB (1) GB0212355D0 (en)
WO (1) WO2003099287A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801108B9 (en) 2004-09-08 2013-11-20 Mitsubishi Tanabe Pharma Corporation Morpholine compounds for the treatment of inflammations
US8273766B2 (en) 2007-04-04 2012-09-25 Kowa Company, Ltd. Tetrahydroisoquinoline compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3593037B2 (en) * 1998-11-20 2004-11-24 エフ.ホフマン−ラ ロシュ アーゲー Pyrrolidine derivative CCR-3 receptor antagonist
AR035205A1 (en) * 2000-09-29 2004-05-05 Glaxo Group Ltd USEFUL COMPOUNDS IN THE TREATMENT OF INFLAMMATORY DISEASES, PROCESS FOR PREPARATION, INTERMEDIARIES AND PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
WO2003099287A1 (en) 2003-12-04
GB0212355D0 (en) 2002-07-10

Similar Documents

Publication Publication Date Title
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
AU2003225580A1 (en) Tricyclic pyrazole derivatives for the treatment of inflammation
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003238455A1 (en) Pyrrole compounds for the treatment of prostaglandin mediated diseases
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
SI1487828T1 (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
EP1611120A4 (en) Novel methods for the treatment of inflammatory diseases
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU2003256650A1 (en) Substituted thiophene carboxamide compounds for the treatment of inflammation
AU2003265842A1 (en) Anabaseine derivatives useful in the treatment of neurodegenerative diseases
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003220483A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU2003272962A1 (en) Remedies for allergic diseases
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003232844A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase